Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
UMC Utrecht
Essen Biotech
Jonsson Comprehensive Cancer Center
xCures
University of Nebraska
Adela, Inc
Var2 Pharmaceuticals
Mayo Clinic
M.D. Anderson Cancer Center
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Day One Biopharmaceuticals, Inc.
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Telix Pharmaceuticals (Innovations) Pty Limited
Tempus AI
Sheffield Teaching Hospitals NHS Foundation Trust
National Cancer Institute (NCI)
Taproot Health
Cedars-Sinai Medical Center
Eastern Cooperative Oncology Group
Quadriga Biosciences, Inc.
Xennials Therapeutics Australia Pty Ltd
Gilead Sciences
Hospices Civils de Lyon
SpeciCare
Celgene
Tocagen Inc.
Swiss Cancer Institute
CureOne
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Shenzhen Second People's Hospital
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
INSYS Therapeutics Inc
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)